Routine invasive versus ischemia-guided strategy in patients with acute inferior ST-elevation myocardial infarction who received fibrinolytic therapy: A prospective randomized controlled pilot trial

Cardioprotective effect of Salvianolic acid B on acute myocardial infarction by promoting autophagy and neovascularization and inhibiting apoptosis

“…Many factors can induce such disease, including smoking, diabetes and metabolic disorders, alcohol consumption, cold‐stress stimulation and coronary artery spasm . AMI is now mainly treated by drug therapy, revascularization therapy, interventional therapy, rehabilitation therapy and routine therapy . Unfortunately, the therapeutic effect is unsatisfactory, and patients often suffer from severe and persistent pain or even death.…”

“…[51] AMI is now mainly treated by drug therapy, [52] revascularization therapy, [53] interventional therapy, [54] rehabilitation therapy [55] and routine therapy. [56] Unfortunately, the therapeutic effect is unsatisfactory, and patients often suffer from severe and persistent pain or even death. Even though the application of the above-mentioned therapies has successfully reduced AMI patients' mortality, they are still facing certain risk of in-hospital death.…”

Costs of treating cardiovascular events in Germany: a systematic literature review

“…However, the results are not comparable across studies from different countries because of potential various treatment patterns, reimbursement systems, different study years, etc. For example, it was reported that the treatment costs of AMI during 6 months post event were $ 2764–4953 (equal to 2014 € 2436–4365 [1]) in the US in 2005 [ 24 ]. In Sweden, the average costs of HF-related hospitalizations was SEK 72,613 (2014 € 8156) per patient per year; in contrast, annual prescription costs were low: on average 3 % of total cost (SEK 3503, 2014 € 393 per patient) [ 25 ].…”